Literature DB >> 11287278

Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.

R Ralhan1, S Agarwal, N Nath, M Mathur, B Wasylyk, A Srivastava.   

Abstract

Alterations in p53 tumour suppressor gene and its expression may be implicated in the pathogenesis of betel- and tobacco-related oral cancer. There is wide regional variation in betel- and tobacco-consuming habits in different parts of the Indian subcontinent. The purpose of this study was to determine the correlations between p53 gene mutations, protein accumulation and serum antibodies in oral precancer and cancer. We analysed 30 potentially malignant oral lesions (leukoplakia) and 30 oral squamous cell carcinomas (SCCs) from northern India because the betel quid-consuming habits are different from those prevalent in other regions of India. p53 mutations were analysed by polymerase chain reaction amplification of genomic DNA and direct sequencing, p53 protein accumulation by immunohistochemical analysis and circulating p53 antibodies by ELISA. p53 gene mutations, analysed within exons 5-9, were observed in five out of 30 (17%) potentially malignant oral lesions and seven out of 30 (23%) oral SCCs. All the mutations were base substitution mutations. Three missense and two nonsense mutations were observed in potentially malignant oral lesions, while six missense and one nonsense mutations were identified in oral SCCs. The probable hot spots for the mutations were identified at codons 126, 136 and 174, which have not been observed thus far. A good correlation was observed between p53 missense mutation, p53 antibodies and p53 protein accumulation in matched potentially malignant and malignant oral lesions. All the potentially malignant and cancerous lesions harbouring missense mutations showed accumulation of p53 protein and the majority of these patients showed circulating p53 antibodies suggesting that serological detection of p53 antibodies may serve as a surrogate marker for p53 alterations in oral lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287278     DOI: 10.1016/s1368-8375(00)00092-0

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

Review 1.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

2.  Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.

Authors:  Yutaka Yamazaki; Itsuo Chiba; Makoto Ishikawa; Chiharu Satoh; Ken-Ichi Notani; Yoichi Ohiro; Yasunori Totsuka; Shigeaki Mizuno; Yoshimasa Kitagawa
Journal:  Odontology       Date:  2008-07-27       Impact factor: 2.634

3.  Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma.

Authors:  Abbas S Khan; Sajjad Ahmad; Zahoor Ullah; Naveed Sadiq; Mohsina Haq; Ahmareen K Sheikh
Journal:  J Taibah Univ Med Sci       Date:  2021-12-31

4.  Novel p53 codon 240 Ser > Thr coding region mutation in the patients of oral squamous cell carcinoma (OSCC).

Authors:  S Saleem; Z A Abbasi; A Hameed; N R Qureshi; M A Khan; A Azhar
Journal:  Tumour Biol       Date:  2014-05-16

5.  Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.

Authors:  Amita Chaube; Mallika Tewari; R S Garbyal; Usha Singh; Hari S Shukla
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

Review 6.  Association of betel nut with carcinogenesis: revisit with a clinical perspective.

Authors:  Rajeshwar N Sharan; Ravi Mehrotra; Yashmin Choudhury; Kamlesh Asotra
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

7.  Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin.

Authors:  Sharifah Nurain Syed Zanaruddin; Pei San Yee; Seen Yii Hor; Yink Heay Kong; Wan Maria Nabillah Wan Abd Ghani; Wan Mahadzir Wan Mustafa; Rosnah Binti Zain; Stephen S Prime; Zainal Ariff Abd Rahman; Sok-Ching Cheong
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.